Clinical Trial Update: Acetyl-L-Carnitine in Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating acetyl-L-carnitine in patients with type 2 diabetes mellitus, including hypertension, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Type 2 Diabetes Mellitus

Drugs mentioned

• Acetyl-L-carnitine (N-acetyl-L-carnitine)

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Diabetes Type 2, Hypertension | Phase 3 | Status: COMPLETED